These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19338383)
1. Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands. van Puijenbroek E; Conemans J; van Grootheest K Drug Saf; 2009; 32(3):255-64. PubMed ID: 19338383 [TBL] [Abstract][Full Text] [Related]
2. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Oosterhuis I; van Hunsel FP; van Puijenbroek EP Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474 [TBL] [Abstract][Full Text] [Related]
3. Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study. Schutte T; Tichelaar J; Reumerman MO; van Eekeren R; Rolfes L; van Puijenbroek EP; Richir MC; van Agtmael MA Drug Saf; 2017 May; 40(5):409-418. PubMed ID: 28120270 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data. De Bruin ML; van Puijenbroek EP; Bracke M; Hoes AW; Leufkens HG Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):99-105. PubMed ID: 16329159 [TBL] [Abstract][Full Text] [Related]
5. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543 [TBL] [Abstract][Full Text] [Related]
6. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583 [TBL] [Abstract][Full Text] [Related]
7. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Inch J; Watson MC; Anakwe-Umeh S Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department. Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501 [TBL] [Abstract][Full Text] [Related]
9. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. de Langen J; van Hunsel F; Passier A; de Jong-van den Berg L; van Grootheest K Drug Saf; 2008; 31(6):515-24. PubMed ID: 18484785 [TBL] [Abstract][Full Text] [Related]
10. Do pharmacists' reports of adverse drug reactions reflect patients' concerns? van Grootheest K; van Puijenbroek EP; de Jong-van den Berg LT Pharm World Sci; 2004 Jun; 26(3):155-9. PubMed ID: 15230363 [TBL] [Abstract][Full Text] [Related]
11. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. van Hunsel F; Passier A; van Grootheest K Br J Clin Pharmacol; 2009 May; 67(5):558-64. PubMed ID: 19552751 [TBL] [Abstract][Full Text] [Related]
12. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal. Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands. Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243 [TBL] [Abstract][Full Text] [Related]
14. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance. Fornasier G; Taborelli M; Francescon S; Polesel J; Aliberti M; De Paoli P; Baldo P Int J Clin Pharm; 2018 Aug; 40(4):795-802. PubMed ID: 29785683 [TBL] [Abstract][Full Text] [Related]
15. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015. van Hunsel F; de Waal S; Härmark L Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293 [TBL] [Abstract][Full Text] [Related]
16. The role of hospital and community pharmacists in pharmacovigilance. van Grootheest AC; de Jong-van den Berg LT Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
18. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals. Rehan HS; Chopra D; Holani SN; Mishra R Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346 [TBL] [Abstract][Full Text] [Related]
19. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre. Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402 [TBL] [Abstract][Full Text] [Related]
20. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]